Levodopa-induced dyskinesia in Parkinson's disease: pathogenesis and emerging treatment strategies
The most commonly used treatment for Parkinson's disease (PD) is levodopa, prescribed in
conjunction with carbidopa. Virtually all patients with PD undergo dopamine replacement …
conjunction with carbidopa. Virtually all patients with PD undergo dopamine replacement …
[HTML][HTML] Immunomodulatory effects of dopamine in inflammatory diseases
Y Feng, Y Lu - Frontiers in immunology, 2021 - frontiersin.org
Dopamine (DA) receptor, a significant G protein-coupled receptor, is classified into two
families: D1-like (D1 and D5) and D2-like (D2, D3, and D4) receptor families, with further …
families: D1-like (D1 and D5) and D2-like (D2, D3, and D4) receptor families, with further …
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Neurotransmitters are considered as a fundamental regulator in the process of neuronal
growth, differentiation and survival. Parkinson's Disease (PD) occurs due to extensive …
growth, differentiation and survival. Parkinson's Disease (PD) occurs due to extensive …
Resveratrol alleviates levodopa-induced dyskinesia in rats
CQ Zheng, HX Fan, XX Li, JJ Li, S Sheng… - Frontiers in …, 2021 - frontiersin.org
Dyskinesia is a serious complication of Parkinson's disease during levodopa (L-DOPA)
treatment. The pathophysiology of L-DOPA-induced dyskinesia (LID) is complex and not …
treatment. The pathophysiology of L-DOPA-induced dyskinesia (LID) is complex and not …
[HTML][HTML] Histamine-4 receptor antagonist ameliorates Parkinson-like pathology in the striatum
Q Fang, H Xicoy, J Shen, S Luchetti, D Dai… - Brain, Behavior, and …, 2021 - Elsevier
Growing evidence indicates that microglia activation and a neuroinflammatory trigger
contribute to dopaminergic cell loss in Parkinson's disease (PD). Furthermore, increased …
contribute to dopaminergic cell loss in Parkinson's disease (PD). Furthermore, increased …
Role of the dopaminergic system in the striatum and its association with functional recovery or rehabilitation after brain injury
A Verduzco-Mendoza, P Carrillo-Mora… - Frontiers in …, 2021 - frontiersin.org
Disabilities are estimated to occur in approximately 2% of survivors of traumatic brain injury
(TBI) worldwide, and disability may persist even decades after brain injury. Facilitation or …
(TBI) worldwide, and disability may persist even decades after brain injury. Facilitation or …
[HTML][HTML] Effects of Chemogenetic inhibition of D1 or D2 receptor-containing neurons of the substantia Nigra and striatum in mice with Tourette syndrome
L Lin, Y Lan, H Zhu, L Yu, S Wu, W Wan… - Frontiers in Molecular …, 2021 - frontiersin.org
As tourette syndrome (TS) is a common neurobehavioral disorder, the primary symptoms of
which include behavioral stereotypies. Dysfunction of the substantia nigra–striatum network …
which include behavioral stereotypies. Dysfunction of the substantia nigra–striatum network …
Chronic H3R activation reduces L-Dopa-induced dyskinesia, normalizes cortical GABA and glutamate levels, and increases striatal dopamine D1R mRNA …
A Avila-Luna, A Gálvez-Rosas, A Aguirre-Pérez… - …, 2023 - Springer
Rationale Dyskinesias induced by L-3, 4-dihydroxyphenylalanine, L-Dopa (LIDs), are the
major complication in the pharmacological treatment of Parkinson's disease. LIDs induce …
major complication in the pharmacological treatment of Parkinson's disease. LIDs induce …
Histamine in the crosstalk between innate immune cells and neurons: Relevance for brain homeostasis and disease
L Bernardino - The Functional Roles of Histamine Receptors, 2021 - Springer
Histamine is a biogenic amine playing a central role in allergy and peripheral inflammatory
reactions and acts as a neurotransmitter and neuromodulator in the brain. In the adult …
reactions and acts as a neurotransmitter and neuromodulator in the brain. In the adult …
[HTML][HTML] Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of …
SK Koski, S Leino, P Panula, S Rannanpää… - Neuroscience …, 2020 - Elsevier
The brain histaminergic and dopaminergic systems closely interact, and some evidence also
suggests significant involvement of histamine in Parkinson's disease (PD), where …
suggests significant involvement of histamine in Parkinson's disease (PD), where …